Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Leukemia, Myeloid, Acute 13Myelodysplastic Syndromes 6Myeloproliferative Disorders 3Leukemia, Myelomonocytic, Chronic 3Advanced Solid Tumour 3Small Cell Lung Carcinoma 2Recurrence 2Multiple Myeloma 2Esophageal Squamous Cell Carcinoma 2Carcinoma, Non-Small-Cell Lung 2Advanced Breast Cancer 2Squamous Cell Carcinoma of Head and Neck 1Ovarian Neoplasms 1Non-Muscle Invasive Bladder Neoplasms 1Neuroma 1Neoplasms 1Neoplasm Metastasis 1Multiple Sclerosis 1Lung Neoplasms 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Monocytic, Acute 1Leukemia, Biphenotypic, Acute 1Idiopathic Pulmonary Fibrosis 1Esophageal Neoplasms 1Diffuse Intrinsic Pontine Glioma 1Depression 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1Blast Crisis 1

Interventions

pembrolizumab 18Specimen Handling 17Magnetic Resonance Spectroscopy 12Biopsy 12Paclitaxel 9Carboplatin 8Radiosurgery 7Nivolumab 7trastuzumab deruxtecan 6Pemetrexed 6Leucovorin 6Irinotecan 6Fulvestrant 6Fluorouracil 6Bevacizumab 6palbociclib 5Oxaliplatin 5Letrozole 5Gemcitabine 5Cetuximab 5Taxes 4Cisplatin 4Capecitabine 4olaparib 3enzalutamide 3durvalumab 3Ipilimumab 3Docetaxel 3130-nm albumin-bound paclitaxel 3sacituzumab govitecan 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasm Metastasis × Injections × 30 days × Clear all
NCT07621601 2026-06-02

A Study of HS-20093 in Patients With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC)

Hansoh BioMedical R&D Company

Phase 3 Not yet recruiting
494 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡